Quest Diagnostics Incorporated logo

Quest Diagnostics Incorporated (Q1UE34)

Market Closed
7 Aug, 19:55
B3 B3
R$
587. 64
0
0%
R$
124.39B Market Cap
20.12 P/E Ratio
5.98% Div Yield
1 Volume
8.71 Eps
R$ 587.64
Previous Close
Add Transaction
Day Range
587.64 587.64
Year Range
464.08 587.64
Want to track Q1UE34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

Q1UE34 closed Friday higher at R$587.64, an increase of 0% from Thursday's close, completing a monthly increase of 16.934% or R$85.1. Over the past 12 months, Q1UE34 stock gained 22.1248%.
Q1UE34 is not paying dividends to its shareholders.
The last earnings report, released on Apr 20, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

Q1UE34 Chart

People also search for

Weg S.A.
R$ 47.63
-1.0183%
Agilent Technologies Inc.
R$ 72.26
0%
Waters Corporation
R$ 476.58
0%
Roper Technologies Inc.
R$ 200.23
0%
WEG S.A.
R$ 47.54
-1.1026%

Quest Diagnostics Incorporated (Q1UE34) FAQ

What is the stock price today?

The current price is R$587.64.

On which exchange is it traded?

Quest Diagnostics Incorporated is listed on B3.

What is its stock symbol?

The ticker symbol is Q1UE34.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 5.98%.

What is its market cap?

As of today, the market cap is 124.39B.

Has Quest Diagnostics Incorporated ever had a stock split?

No, there has never been a stock split.

Quest Diagnostics Incorporated Profile

Professional Services Industry
Industrials Sector
James E. Davis CEO
B3 Exchange
- ISIN
US Country
57,000 Employees
- Last Dividend
- Last Split
17 Dec 1996 IPO Date

Overview

Quest Diagnostics Incorporated, established in 1967 and based in Secaucus, New Jersey, is a prominent provider of diagnostic testing, information, and services both in the United States and internationally. The company operates with the mission to deliver critical diagnostic insights that lead to informed healthcare decisions. Using its extensive network of laboratories, patient service centers, and healthcare professionals, Quest Diagnostics offers a wide range of diagnostic information services. These services cater to a diverse clientele including physicians, hospitals, patients, health plans, government agencies, employers, and pharmaceutical companies. Through its flagship Quest Diagnostics brand and others such as AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, the company aims to improve health outcomes by making better information available to the healthcare ecosystem.

Products and Services

  • Diagnostic Information Services
  • These encompass routine and non-routine clinical tests, advanced clinical testing, and anatomic pathology testing. Quest Diagnostics utilizes a vast array of technological platforms to provide critical diagnostic information that supports disease prevention, diagnosis, treatment, and management.

  • Risk Assessment Services for Life Insurance Industry
  • Quest Diagnostics provides comprehensive risk assessment services tailored to the needs of the life insurance sector. These services are designed to help insurance companies evaluate the health risks of policy applicants through a variety of diagnostic tests and assessments.

  • Healthcare Information Technology Solutions
  • Offering cutting-edge information technology solutions, Quest Diagnostics helps healthcare organizations and clinicians enhance efficiency and patient care. These solutions encompass a wide range of IT services designed to facilitate the secure exchange of health information, improve lab ordering processes, and streamline patient record management.

Contact Information

Address: 500 Plaza Drive
Phone: 973 520 2700